Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Arvinas management update

    Arvinas Inc., New Haven, Conn. Business: Cancer, Inflammation, Autoimmune Hired: Manuel Litchman as president and CEO, formerly SVP and global program head at Novartis AGs Novartis Pharmaceuticals Corp. subsidiary

    Published on 1/19/2015
  • Aveo Pharmaceuticals management update

    Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Business: Cancer Hired: Michael Needle as CMO, formerly CMO of Array BioPharma Inc.

    Published on 1/19/2015
  • CoLucid board of directors update

    CoLucid Pharmaceuticals Inc., Durham, N.C. Business: Neurology Appointed: Martin Edwards, senior partner at Novo Ventures; and Luc Marengere, managing partner at TVM Capital Life Science

    Published on 1/19/2015
  • DBV management update

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT), Bagneux, France Business: Inflammation, Diagnostic Transitioned: Bertrand Dupont to senior EVP of technology from chief technical officer; Laurent Martin to senior EVP …

    Published on 1/19/2015
  • DiaCarta board of directors update

    DiaCarta Inc., Hayward, Calif. Business: Diagnostic, Supply/Service Appointed: Weixin Xu, principal at BVCF

    Published on 1/19/2015
  • Egalet management update

    Egalet Corp. (NASDAQ:EGLT), Wayne, Pa. Business: Neurology, Cardiovascular, Drug delivery Hired: Deanne Melloy as chief commercial officer, formerly EVP and COO of Shionogi & Co. Ltd.s Shionogi Inc. U.S. company

    Published on 1/19/2015
  • Endo management update

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Business: Neurology, Genitourinary Departing: Don DeGolyer as COO, effective March 1

    Published on 1/19/2015
  • Erytech management update

    Erytech Pharma S.A. (Euronext:ERYP), Lyon, France Business: Cancer, Endocrine/Metabolic, Hematology Departing: Pierre-Olivier Goineau as VP and COO

    Published on 1/19/2015
  • Genkyotex board of directors update

    Genkyotex S.A., Plan-les-Ouates, Switzerland Business: Renal, Hepatic, Pulmonary Appointed: Claudio Nessi, partner at NeoMed Management

    Published on 1/19/2015
  • Integrated Diagnostics management update

    Integrated Diagnostics Inc., Seattle, Wash. Business: Diagnostic Hired: Douglas Sanders as CFO, formerly CFO of CMC Biologics A/S

    Published on 1/19/2015
  • KaloBios management update

    KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Business: Antibodies, Infectious, Cancer Retired: David Pritchard as president, CEO and a director; he is succeeded by CFO Herb Cross as interim …

    Published on 1/19/2015
  • Keryx management update

    Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), New York, N.Y. Business: Endocrine/Metabolic, Renal Transitioning: Greg Madison to president and CEO from COO; he succeeds CEO Ron Bentsur

    Published on 1/19/2015
  • Marinus management update

    Marinus Pharmaceuticals Inc. (NASDAQ:MRNS), New Haven, Conn. Business: Neurology Hired: Albena Patroneva as CMO, formerly executive medical director and therapeutic area group advisor CNS at Takeda Pharmaceutical Co. …

    Published on 1/19/2015
  • Mission Therapeutics management update

    Mission Therapeutics Ltd., Cambridge, U.K. Business: Cancer Hired: Anker Lundemose as CEO, formerly CEO of Bionor Pharma ASA

    Published on 1/19/2015
  • Orphazyme board of directors update

    Orphazyme ApS, Copenhagen, Denmark Business: Endocrine/Metabolic Appointed: Remi Droller, managing partner at Kurma Partners

    Published on 1/19/2015
  • Oryzon management update

    Oryzon Genomics S.A., Barcelona, Spain Business: Cancer, Neurology, Diagnostic Hired: Greg Weaver as EVP and CFO, formerly CFO of Fibrocell Science Inc.; he succeeds Enric Rello, who remains as CFO in Spain and COO

    Published on 1/19/2015
  • Stealth BioTherapeutics management update

    Stealth BioTherapeutics Inc., Newton, Mass. Business: Cardiovascular, Renal, Endocrine/Metabolic Hired: Mark Colonnese as CFO, formerly EVP and CFO of Transgenomic Inc.

    Published on 1/19/2015
  • Unilife management update

    Unilife Corp. (NASDAQ:UNIS; ASX:UNS), York, Pa. Business: Drug delivery Hired: David Hastings as CFO, effective Feb. 23, formerly CFO of Incyte Corp.; he succeeds interim CFO Dennis Pyers, who remains as SVP and …

    Published on 1/19/2015
  • uniQure management update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Business: Hematology, Neurology, Endocrine/Metabolic Hired: Matthew Kapusta as CFO, formerly SVP of corporate development, strategic planning and national accounts …

    Published on 1/19/2015
  • Altor BioScience management update

    Altor BioScience Corp., Miramar, Fla. Business: Cancer, Infectious, Autoimmune Hired: Kevin Taylor as CBO, formerly CBO of Nuron Biotech Inc.

    Published on 1/12/2015
  • BBB Therapeutics management update

    BBB Therapeutics B.V., Leiden, the Netherlands Business: Drug delivery, Cancer, Neurology Resigned: Anders Harfstrand as CEO

    Published on 1/12/2015
  • BioCryst management update

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. Business: Cancer, Endocrine/Metabolic, Infectious Hired: Lynne Powell as SVP and chief commercial officer, effective Jan. 26, formerly SVP of North American …

    Published on 1/12/2015
  • BioPorto Diagnostics management update

    BioPorto Diagnostics A/S, Gentofte, Denmark Business: Diagnostic, Antibodies Departing: Otto Rasmussen as CFO, effective Jan. 31; he is succeeded by Birgitte Svendsen, CEO of Pecunia Consult ApS, as interim CFO

    Published on 1/12/2015
  • Catalyst Pharma management update

    Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Neurology Promoted: David Muth to EVP and chief commercial officer, a newly created position, from EVP of corporate development

    Published on 1/12/2015
  • Cepheid management update

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Business: Microfluidics, Diagnostic, Pharmacogenetics Departing: Andrew Miller as EVP and CFO, effective Feb. 3; he is succeeded by VP and Corporate Controller Daniel Madden…

    Published on 1/12/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993